“…The most investigated have been leukaemia [ 20 – 24 ], colon cancer [ 25 – 32 ], melanoma [ 33 – 37 ], pancreatic cancer [ 14 , 31 , 38 ] and prostate cancer [ 39 – 41 ]. Similar results have been described for the treatment of non-small-cell lung cancer (NSCLC) [ 16 ], breast cancer [ 31 , 42 ], ovarian cancer [ 31 , 43 , 44 ], hepatocellular carcinoma [ 45 , 46 ], malignant mesothelioma [ 47 , 48 ], thyroid cancer [ 49 , 50 ], oral squamous cell carcinoma [ 51 ], neuroblastoma [ 52 ] and glioma, including the difficult-to-treat glioblastoma multiform (GBM) [ 16 , 53 , 54 ].…”